Further Information
Bile acid receptor, Farnesoid X-activated receptor, Farnesol receptor HRR-1, Nuclear receptor subfamily 1 group H member 4, Retinoid X receptor-interacting protein 14, RXR-interacting protein 14, NR1H4, BAR, FXR, HRR1, RIP14
For WB starting dilution is: 1:1000
NR1H4 is a Ligand-activated transcription factor. Receptor for bile acids such as chenodeoxycholic acid, lithocholic acid and deoxycholic acid. Represses the transcription of the cholesterol 7-alpha-hydroxylase gene (CYP7A1) through the induction of NR0B2 or FGF19 expression, via two distinct mechanisms. Activates the intestinal bile acid-binding protein (IBABP). Activates the transcription of bile salt export pump ABCB11 by directly recruiting histone methyltransferase CARM1 to this locus.
- Meyer Zu Schwabedissen, H.E., et al. Hepatology 52(5):1797-1807(2010)
- Popescu, I.R., et al. FEBS Lett. 584(13):2845-2851(2010)
- Gadaleta, R.M., et al. Biochim. Biophys. Acta 1801(7):683-692(2010)
- Roberts, K.E., et al. Gastroenterology 139(1):130-139(2010)
Supplied in PBS with 0.09% (W/V) sodium azide.
batch dependent
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Predicted species reactivity based on immunogen sequence: Bovine
This NR1H4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 18-46 amino acids from the N-terminal region of human NR1H4.
9971
Bile acid receptor
NR1H4
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
56 kDa
Q96RI1
46577705
This antibody is purified through a protein A column, followed by peptide affinity purification.
Obesity,Signal Transduction
Q96RI1
Optimal dilutions for each application to be determined by the researcher.